NAVINFLUOR Q3 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹892 Cr
verified against source
Revenue YoY
47%
reported change
EBITDA
₹308 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Navin Fluorine delivered an exceptional Q3 FY26 with 47% YoY revenue growth to ₹892 crores and 109% EBITDA growth to ₹308 crores, with margins expanding 1,020bps to 34.5%. All three verticals—HPP (₹412cr, +35%), Specialty Chemicals (₹354cr, +60% record), and CDMO (₹127cr, +61%)—posted strong growth driven by successful project commissioning (CGMP4 Phase 1, AHF) and deepening customer partnerships. Management confirmed FY26 annual EBITDA margin guidance of approximately 30%, achievable given operating leverage across the portfolio. The company has commissioned all Wave 1 capex projects, with Wave 2 (MPPD debottlenecking, R32 expansion, Chemos project) on track for FY27. The liquid cooling opportunity ($3B market) and India Semiconductor Mission 2.0 provide multi-year growth visibility. Key risks include sulfur-driven input cost inflation, ongoing agrochemical pricing pressure, and campaign-driven margin variability—management deflected questions on which specific segments face margin downside risk, indicating product-mix opacity.
Colored figures show movement against the previous available record.
Guidance to track
- Management stated Navin Fluorine should be viewed as a 30% annual EBITDA margin business with ±200bps quarterly variability, up from historical ~25% guidance.
- Progressing toward $100M CDMO revenue target with strong near-term catalysts from EU partner MSA and multiple expected molecule readouts in FY27.
- Kimox project (Q1 FY27), MPPD debottlenecking (Q3 FY27), and R32 expansion (Q3 FY27) all on track as committed.
- Staff costs expected at 7-8% of revenue going forward, down from historical double-digit levels, reflecting operational optimization.
Risks flagged
- Sulfur prices continue increasing, directly impacting HF production costs. Management flagged this as the primary margin risk requiring continuous pricing pass-through vigilance.
- Perennial pricing pressure remains in the ATM segment; management acknowledged this but emphasized their shift from transactional to solution-provider relationships as mitigation.
- Analyst pressed management on which segment faces downside margin risk given current favorable product mix. Management deflected, stating it's 'not as linear' and product-mix dependent, suggesting limited transparency on margin sustainability by segment.
- AHF capacity commissioned for downstream integration but electronic-grade qualification is taking longer than initially expected. Management clarified solar is interim step to electronics grade, with BF3 semiconductor applications part of longer-term roadmap.
Key quotes
- We have always communicated this very strongly that our priority has always remained on manufacturing excellence as number one priority. We are consistently driving economies and removing inefficiencies in the system.
- This is a license to grow capacity... by putting this capacity we are signaling that we will continue to develop chemistry and capability in downstream applications to grow this.
- So I think it's safe to think of Navin as a 30% annual number. But let's not kind of hold that on a quarterly sort of treadmill run rate.
Research modules